BioHealth News Archive
Study: DC-area ranks 10th in venture investment – Technical.ly DC
We know from following the Rise of the Rest that D.C. isn’t in the top three for metros venture capital investments, but a new…
Read More
CIT Announces FY2018 Solicitation for Commonwealth Research Commercialization Fund
The Center for Innovative Technology (CIT) announced today the Commonwealth Research Commercialization Fund (CRCF) Request for Proposals (RFP) for FY2018. {iframe}https://globenewswire.com/news-release/2017/10/05/1141562/0/en/CIT-Announces-FY2018-Solicitation-for-Commonwealth-Research-Commercialization-Fund.html{/iframe}
Read More
TEDCO awards $1 million for stem cell projects – Maryland Daily Record
TEDCO, the Maryland Technology Development Corporation, awarded four recipients more than $1 million for stem cell research for validation and commercialization of products. LifeSprout…
Read More
Hopkins Tech Ventures to expand FastForward incubator program for university students – Baltimore Business Journal
Johns Hopkins Tech Ventures is expanding its entrepreneurship and incubation services for university students. {iframe}https://www.bizjournals.com/baltimore/news/2017/10/05/hopkins-tech-ventures-to-expand-fastforward.html{/iframe}
Read More
Meet DC’s newest incubator: Accelspace – Technical.ly DC
What happens to startups when they’ve outgrown coworking, but aren’t ready a whole office suite? There’s an incubator for that. Accelspace is #dctech’s latest…
Read More
University of Maryland receives $219.5M gift from Clark Foundation, largest in school’s history – Baltimore Business Journal
The University of Maryland will receive a $219.5 million donation from the A. James and Alice B. Clark Foundation created by the late contracting…
Read More
Emergent BioSolutions Awarded U.S. Department of State Contract Valued at Up to $25 Million to Supply Nerve Agent Antidote Auto-Injector NYSE:EBS
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at up to approximately $25 million by the U.S. Department…
Read More
Rock Health: 16% of digital health companies funded in Q3 2017 led by women – MedCity News
A digital health report from Rock Health showed that women-led companies and geographic diversity continued to build in the third quarter. In the three…
Read More
The Geographic Concentration of Venture Capital – CityLab
When it comes to high-tech startups, we hear a lot about the so-called “rise of the rest.” As the nation’s leading centers of high-tech…
Read More
Qiagen achieves ISO certification for state-of-the-art quality in forensics
Qiagen has announced that its manufacturing and supply chain for consumables and other products for forensic and human identity testing has been certified by…
Read More
Universities key to regional cooperation among Md., D.C. and Va. – Baltimore Sun
Despite the jurisdictional posturing in Maryland, Virginia and Washington D.C. over a possible Amazon headquarters, a new FBI building or a national football stadium,…
Read More
BioMarker Strategies Announces Phase I National Cancer Institute Grant to Develop Companion Diagnostic to Identify Patients with Head and Neck Cancer Who Are Most Likely to Respond to Treatment with Cetuximab | Business Wire
BioMarker Strategies, LLC today announced that the National Cancer Institute (NCI) has awarded the Company a Phase I Small Business Innovation Research (SBIR) grant…
Read More
NEBGH President & CEO Laurel Pickering to Join Leading Digital Health Company, WellDoc, as Chief Revenue Officer
WellDoc®, a leading digital health company, announced today the appointment of Laurel Pickering, president and CEO of Northeast Business Group on Health (NEBGH), as…
Read More
What’s next for pharma innovation in China | McKinsey & Company
Three prominent Chinese executives discuss the progress of local companies in drug innovation and the evolving regulatory environment. {iframe}https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-next-for-pharma-innovation-in-china?cid=other-eml-alt-mip-mck-oth-1710&hlkid=7c63407c9d134d0889c3acf8f3b25591&hctky=3027237&hdpid=001a5388-2ecf-4f39-b534-6fdd99bc7190{/iframe}
Read More
Emergent BioSolutions Completes Acquisition of Raxibacumab, an FDA-Approved Anthrax Monoclonal Antibody, From GSK
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed its acquisition of raxibacumab, a fully human monoclonal antibody approved by the U.S. Food…
Read More